Anika Therapeutics, Inc.
ANIK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000898437
In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Anika Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +1 vs. Q4 2024
- Shares held
- 12.7M
- +192.2K (+1.5%) vs. Q4 2024
- Total value
- $190.7M
- −$14.8M (−7.2%) vs. Q4 2024
- New holders
- 16
- 33 more added
- Sold out
- 15
- 42 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 133 | $179.0M |
| Q1 2026 | 130 | $179.1M |
| Q4 2025 | 126 | $117.5M |
| Q3 2025 | 117 | $115.0M |
| Q2 2025 | 104 | $134.2M |
| Q1 2025 | 108 | $190.7M |
| Q4 2024 | 109 | $206.2M |
| Q3 2024 | 122 | $323.5M |
| Q2 2024 | 114 | $335.3M |
| Q1 2024 | 120 | $340.4M |
| Q4 2023 | 117 | $300.2M |
| Q3 2023 | 117 | $242.3M |
| Q2 2023 | 117 | $340.4M |
| Q1 2023 | 121 | $375.6M |
| Q4 2022 | 125 | $388.0M |
| Q3 2022 | 123 | $320.5M |
| Q2 2022 | 126 | $302.2M |
| Q1 2022 | 119 | $341.4M |
| Q4 2021 | 127 | $483.3M |
| Q3 2021 | 131 | $559.5M |
| Q2 2021 | 139 | $568.9M |
| Q1 2021 | 146 | $543.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 528,617 | $7.95M | 0.01% | +1000.0% | Added |
| Boothbay Fund Management, LLC | 529,503 | $7.96M | 0.28% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 539,614 | $8.11M | 0.02% | +63,901+13.4% | Added |
| Dimensional Fund Advisors LP | 613,972 | $9.23M | 0.00% | −43,383−6.6% | Reduced |
| Vanguard Group Inc | 777,405 | $11.7M | 0.00% | +12,135+1.6% | Added |
| Caligan Partners LP | 1,435,130 | $21.6M | 4.50% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,519,261 | $22.8M | 0.00% | −38,621−2.5% | Reduced |
| Trigran Investments, Inc. | 2,041,853 | $30.7M | 4.52% | +20,075+1.0% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,367−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,039−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,859−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,096−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,990−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,576−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,426−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,620−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,223−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,176−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Virtus Fund Advisers, LLC | – | – | – | – | Not filed |